Cardiac Sarcoidosis Diagnostic Challenges and Management: A Case Report and Literature Review.
arrhythmia
atrioventricular conduction abnormality
cardiac manifestations
cardiac sudden death
case report
extrapulmonary sarcoidosis
heart failure
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
27
03
2022
accepted:
08
05
2022
entrez:
15
6
2022
pubmed:
16
6
2022
medline:
16
6
2022
Statut:
epublish
Résumé
Sarcoidosis can be presented as cardiac sarcoidosis (CS), which is challenging to diagnose due to its clinical silence. Ventricular arrhythmias and atrioventricular blocks can be fatal and cause sudden death in patients with cardiac sarcoidosis. Five percent of sarcoidosis patients have clinically evident cardiac sarcoidosis. However, autopsy reports and imaging studies have shown a higher prevalence of cardiac involvement. Early recognition is important to prevent such detrimental consequences. Cardiac sarcoidosis is increasingly being diagnosed owing to increased awareness among physicians and new diagnostic tools like MRI and positron emission tomography (PET) scan replacing traditional endomyocardial biopsy. A definitive diagnosis of CS remains challenging due to the non-specific clinical findings that can present similar symptoms of common cardiac disease; therefore, the imaging and biopsies are substantial for diagnosis confirmation. Pharmacological and Implantable devices are two main therapeutic approaches in cardiac sarcoidosis, in which steroids and pacemaker therapy have shown better outcomes. This review summarizes the available data related to the prevalence, prognosis, diagnosis, and management of cardiac sarcoidosis.
Identifiants
pubmed: 35702472
doi: 10.7759/cureus.24850
pmc: PMC9177213
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e24850Informations de copyright
Copyright © 2022, Jaiswal et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Cardiol. 2005 Jan 1;95(1):143-6
pubmed: 15619415
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55
pubmed: 10430755
Eur Heart J Case Rep. 2018 Oct 11;2(4):yty103
pubmed: 31020179
Expert Rev Respir Med. 2019 Jun;13(6):507-520
pubmed: 30099918
Am J Cardiol. 2001 Nov 1;88(9):1006-10
pubmed: 11703997
J Am Coll Cardiol. 2003 Jan 15;41(2):322-9
pubmed: 12535829
Heart. 2006 Feb;92(2):282-8
pubmed: 16415205
Rom J Intern Med. 2019 Mar 1;57(1):7-13
pubmed: 30375351
Oxf Med Case Reports. 2019 May 31;2019(5):omz033
pubmed: 31198569
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Nov;165(4):347-359
pubmed: 34671170
Cardiol J. 2020;27(3):272-277
pubmed: 30234899
Pol Merkur Lekarski. 2016 Aug;41(242):101-6
pubmed: 27591449
Int J Cardiol. 2004 Nov;97(2):173-82
pubmed: 15458680
J Intern Med. 2011 Nov;270(5):461-8
pubmed: 21535250
Case Rep Med. 2019 Mar 6;2019:4341098
pubmed: 30956665
Am J Med Sci. 2018 Feb;355(2):113-125
pubmed: 29406038
Can J Cardiol. 2013 Aug;29(8):1015.e1-3
pubmed: 23246240
Heart Lung. 2016 Nov - Dec;45(6):515-516
pubmed: 27692681
Am Heart J. 1999 Aug;138(2 Pt 1):299-302
pubmed: 10426842
Circulation. 1978 Dec;58(6):1204-11
pubmed: 709777
Acta Clin Belg. 2021 Aug;76(4):289-293
pubmed: 32000632
Am J Med. 1977 Jul;63(1):86-108
pubmed: 327806
Chest. 1993 Jan;103(1):253-8
pubmed: 8417889
Am J Med. 1996 Apr;100(4):423-7
pubmed: 8610729
Cardiovasc Pathol. 2010 Jul-Aug;19(4):e119-23
pubmed: 19502084
Am J Cardiol. 2019 Feb 1;123(3):513-522
pubmed: 30503798
World J Cardiol. 2020 Jun 26;12(6):291-302
pubmed: 32774781
Circulation. 2007 Nov 6;116(19):2216-33
pubmed: 17959655